Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity

Raf kinase inhibitory protein (RKIP) functions as a chemo-immunotherapeutic sensitizer of cancers, but regulation of RKIP on tumor radiosensitivity remains largely unexplored. In this study, we investigate the role and mechanism of RKIP in nasopharyngeal carcinoma (NPC) radioresistance. The results...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Yuan, Li, Yi, Hong-Mei, Yi, Hong, Qu, Jia-Quan, Zhu, Jin-Feng, Li, Li-Na, Xiao, Ta, Zheng, Zhen, Lu, Shan-Shan, Xiao, Zhi-Qiang
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905486/
https://ncbi.nlm.nih.gov/pubmed/26862850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7201
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars